Comparative Analysis of Median Nerve Parameters for Carpal Tunnel Syndrome (CTS) Diagnosis: Ultrasound Versus Nerve Conduction Studies (NCS)

NCT ID: NCT06926777

Last Updated: 2025-04-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-01

Study Completion Date

2025-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparative Analysis of Median Nerve Parameters for Carpal Tunnel Syndrome (CTS) Diagnosis: Ultrasound vs. Nerve Conduction Study (NCS) This clinical study aims to determine whether ultrasound can be as practical as NCS in diagnosing CTS. It will also evaluate the accuracy of different median nerve measurements in both tests.

The main questions it aims to answer are:

Can ultrasound accurately detect CTS compared to NCS? Which median nerve measurements (such as size, speed, or function) are most useful for diagnosis? Researchers will compare ultrasound and NCS results in patients with CTS symptoms to determine which test is more reliable and patient-friendly.

Participants will:

1. Undergo both an ultrasound and a NCS for comparison.
2. Visit the clinic for testing and evaluation as part of the study.
3. Provide information about their symptoms and medical history related to CTS. This study aims to improve diagnosis accuracy and explore whether ultrasound could be a more comfortable and quicker alternative to NCS for detecting CTS.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study aims to compare ultrasound and NCS for diagnosing CTS by analyzing key median nerve parameters in both tests. CTS is a common condition caused by compression of the median nerve at the wrist, leading to symptoms such as numbness, tingling, and weakness in the hand. Accurate diagnosis is essential to ensure appropriate treatment.

Currently, NCS is considered the standard test for CTS diagnosis, measuring nerve function by assessing conduction velocity and latency. However, ultrasound has emerged as a potential alternative by providing structural imaging of the median nerve, including parameters like cross-sectional area (CSA), echogenicity, and flattening ratio.

The primary objective of this study is to determine whether ultrasound can be a reliable, non-invasive, and patient-friendly alternative to NCS for CTS diagnosis. By comparing nerve measurements obtained from both methods, researchers aim to evaluate their diagnostic accuracy, sensitivity, and specificity.

Participants with suspected CTS will undergo both ultrasound and NCS for comparison. Data will be analyzed to determine which test provides the most precise and clinically useful information. The findings of this study may help refine diagnostic protocols, potentially reducing the need for NCS in certain cases and offering a faster, more comfortable option for patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Carpal Tunnel Syndrome (CTS) Nerve Conduction Ultrasound

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ultrasound Diagnostic Arm

Participants in this arm will undergo ultrasound imaging of the median nerve at the wrist. Measurements such as CSA and flattening ratio will be recorded. The goal is to evaluate ultrasound's effectiveness in diagnosing CTS compared to NCS.

Group Type OTHER

Nerve Conduction Study

Intervention Type DIAGNOSTIC_TEST

This study involves two diagnostic interventions for evaluating CTS:

Ultrasound Examination (Diagnostic Intervention)

1. A high-frequency ultrasound probe will be used to assess the median nerve at the wrist.
2. Parameters measured include cross-sectional area, flattening ratio, and echogenicity.

The goal is to determine if ultrasound can accurately diagnose CTS compared to NCS.

NCS (Diagnostic Intervention)

1. Surface electrodes will be placed on the skin to stimulate and record median nerve conduction.
2. Parameters such as latency, conduction velocity, and amplitude will be recorded.
3. NCS serves as the gold standard for diagnosing CTS and will be used for comparison with ultrasound results.

Each participant will undergo both ultrasound and NCS, allowing researchers to compare their effectiveness in diagnosing CTS.

Nerve Conduction Study (NCS) Group (Diagnostic Arm)

Participants in this arm will undergo an NCS to assess median nerve function. Parameters such as nerve conduction velocity, latency, and amplitude will be recorded. NCS findings will serve as the gold standard for comparison with ultrasound results.

Group Type OTHER

Nerve Conduction Study

Intervention Type DIAGNOSTIC_TEST

This study involves two diagnostic interventions for evaluating CTS:

Ultrasound Examination (Diagnostic Intervention)

1. A high-frequency ultrasound probe will be used to assess the median nerve at the wrist.
2. Parameters measured include cross-sectional area, flattening ratio, and echogenicity.

The goal is to determine if ultrasound can accurately diagnose CTS compared to NCS.

NCS (Diagnostic Intervention)

1. Surface electrodes will be placed on the skin to stimulate and record median nerve conduction.
2. Parameters such as latency, conduction velocity, and amplitude will be recorded.
3. NCS serves as the gold standard for diagnosing CTS and will be used for comparison with ultrasound results.

Each participant will undergo both ultrasound and NCS, allowing researchers to compare their effectiveness in diagnosing CTS.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nerve Conduction Study

This study involves two diagnostic interventions for evaluating CTS:

Ultrasound Examination (Diagnostic Intervention)

1. A high-frequency ultrasound probe will be used to assess the median nerve at the wrist.
2. Parameters measured include cross-sectional area, flattening ratio, and echogenicity.

The goal is to determine if ultrasound can accurately diagnose CTS compared to NCS.

NCS (Diagnostic Intervention)

1. Surface electrodes will be placed on the skin to stimulate and record median nerve conduction.
2. Parameters such as latency, conduction velocity, and amplitude will be recorded.
3. NCS serves as the gold standard for diagnosing CTS and will be used for comparison with ultrasound results.

Each participant will undergo both ultrasound and NCS, allowing researchers to compare their effectiveness in diagnosing CTS.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Adults aged 18 years or older.
2. Patients with clinical symptoms of CTS, including numbness, tingling, pain, or weakness in the hand.
3. Positive findings on clinical examination, such as Tinel's sign, Phalen's test, or Durkan's test.
4. Willingness to undergo both ultrasound and NCS for diagnostic evaluation.

Exclusion Criteria

1. Previous surgery for CTS in the affected hand.
2. History of peripheral neuropathy such as diabetic neuropathy
3. Other neuromuscular disorders affecting the upper limb such as cervical radiculopathy.
4. Pregnant women.
5. Severe comorbid conditions that may interfere with study participation.
6. Inability to provide informed consent.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Combined Military Hospital Kohat Pakistan

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Syed Tameem Ul Hassan

Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Syed Tameem Ul Hassan, MBBS, FCPS

Role: PRINCIPAL_INVESTIGATOR

Combined Military Hospital Kohat

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Combined Military Hospital

Kohat, KPK, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Syed Tameem Ul Hassan, MBBS, FCPS

Role: CONTACT

00923368885877

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Syed Tameem Ul Hassan, MBBS, FCPS

Role: primary

00923368885877

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

E-2005/A/114

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.